Vaccination perspectives: the Qdenga® dilemma
Journal of Travel Medicine·
- DOI
- 10.1093/jtm/taaf023
- PMID
- 40057973
- PMCID
- —
- OpenAlex
- W4408269633
- Study type
- Journal article
- Publisher
- Oxford University Press (OUP)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The paper is relevant to travel medicine because it discusses how Qdenga is considered in vaccine decision-making for travellers. It also highlights the need for careful interpretation of evolving guidance and evidence.
Structured evidence summary
Research question
The article addresses how the Qdenga dengue vaccine is being discussed in travel medicine, especially the balance between possible benefits, safety questions, and concerns for dengue-naive people.
Study design
This appears to be a journal article with a perspective or commentary style rather than an original clinical study. The abstract does not describe methods, data collection, or an analytic design.
Population and setting
The discussion is set in travel medicine and refers to travellers, including people with no prior dengue exposure. The topic is dengue vaccination in an international guidance context.
Main findings
The abstract says the vaccine raises both promise and unresolved concerns. It notes continuing debate about effectiveness, safety, and possible risks for dengue-naive individuals, alongside differing guidance and changing evidence.
Public-health relevance
The paper is relevant to travel medicine because it discusses how Qdenga is considered in vaccine decision-making for travellers. It also highlights the need for careful interpretation of evolving guidance and evidence.
Important limitations
The abstract does not report study methods, sample size, or primary data, so the evidence is limited to a high-level discussion. This summary is also constrained by the supplied single-article abstract and metadata; the original paper is needed for decision-grade interpretation.
GIDS interpretation
This item is discoverable as background literature on dengue vaccination, travel medicine, and vaccine safety. It should be treated as contextual discussion rather than as evidence of a live surveillance signal.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 10 auditable classifier relationships to diseases, places, topics, and study design.